Yun Li joined SAI MedPartners Asia in 2006. As a key member of Asia team, she has focused on providing broad strategic support to MNC and local pharma and medical device companies covering extensive scope of project types and therapeutic areas.

She supervises and manages project delivery and the project team with over 15 years of experience conducting in-depth interviews with senior management of major players in the healthcare industry, including regulators, medical device and pharmaceutical companies, physicians, distributors, drugstores, patients, and other industry experts.

Ms. Li has solid experience in a wide range of therapeutic areas, such as respiratory, rare diseases, immunology, oncology, cardiovascular, GI, infectious diseases, etc.

She has extensive experience in regulatory/policy analysis, new product market opportunity assessment, strategic market assessments, competitive analysis and benchmarking, assessment of M&A and licensing opportunities, and BD support